Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


EBERT CHARLES D Create: Alert

All | News | Filings
Date FiledTypeDescription
11/08/2013 4 EBERT CHARLES D (SVP, BRANDS R&D) has filed a Form 4 on Actavis plc
Txns: Sold 10,877 shares @ $158.75, valued at $1.7M
10/03/2013 4 EBERT CHARLES D (SVP, BRANDS R&D) has filed a Form 4 on Actavis plc
Txns: Granted 18,488 shares @ $0
10/03/2013 3 EBERT CHARLES D (Sr. VP, Brands R & D) has filed a Form 3 on Actavis plc
10/02/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
08/13/2013 4/A Form 4 - Statement of changes in beneficial ownership of securities [amend]
03/08/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/07/2013 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on Actavis, Inc.
Txns: Paid exercise price by delivering 1,331 shares @ $86.46, valued at $115.1k
03/05/2013 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on Actavis, Inc.
Txns: Paid exercise price by delivering 1,761 shares @ $85.54, valued at $150.6k
03/16/2012 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,265 shares @ $59.21, valued at $74.9k
03/12/2012 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Granted 3,342 shares @ $0
Granted 2,566 shares @ $0
03/01/2012 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Sold 1,000 shares @ $58.7715, valued at $58.8k
Sold 3,981 shares @ $58.811, valued at $234.1k
Exercised 1,000 options to buy @ $25.64, valued at $25.6k
02/28/2012 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,458 shares @ $58.17, valued at $84.8k
06/01/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
03/15/2011 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 616 shares @ $56.89, valued at $35k
03/08/2011 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,295 shares @ $56.79, valued at $73.5k
12/07/2010 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Sold 3,639 shares @ $51, valued at $185.6k
09/02/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
03/16/2010 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Sold 1,200 shares @ $40.88, valued at $49.1k
Sold 1,500 shares @ $40.86, valued at $61.3k
Sold 850 shares @ $40.87, valued at $34.7k
Sold 200 shares @ $40.875, valued at $8.2k
Sold 200 shares @ $40.865, valued at $8.2k
Sold 24,650 shares @ $40.85, valued at $1M
Paid exercise price by delivering 1,265 shares @ $41.37, valued at $52.3k
Exercised 1,600 options to buy @ $38.92, valued at $62.3k
Exercised 6,400 options to buy @ $38.92, valued at $249.1k
Exercised 4,843 options to buy @ $26.14, valued at $126.6k
Exercised 8,757 options to buy @ $26.14, valued at $228.9k
12/11/2009 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC
Txns: Sold 19,000 shares @ $38.25, valued at $726.8k
Exercised 3 options to buy @ $27.88, valued at $83.6
Exercised 10,997 options to buy @ $27.88, valued at $306.6k
Exercised 3,838 options to buy @ $26.4, valued at $101.3k
Exercised 4,162 options to buy @ $26.4, valued at $109.9k
08/13/2009 4 EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy